Andrea Allmendinger ten23 health

Prof. Andrea Allmendinger, PhD, joined ten23 health in 2023 as Chief Scientific Officer. Prior to that, she held the position of Principal Scientist in Pharmaceutical Development for parenteral products at Roche in Basel from 2010 to 2021. She studied Pharmacy at the University of Heidelberg, Germany, and University College London, UK, and earned her Ph.D. in Pharmaceutical Sciences from the University of Basel, Switzerland. In 2025, she was appointed Professor of Pharmaceutical Technology at the University of Freiburg. Her research focuses on novel parenteral drug formulations and device solutions to enhance product stability and usability. She is an expert in pharmaceutical development of combination products and brings extensive expertise in the development of freeze-dried parenteral formulations and lyophilization process optimization, and technology transfer.